Skip to search.
 FTSE 100 Up 0.65%

More On FRX

Quotes

Derivatives

  • Warrants
  • Investment Products

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

(FRX)

-NYSE
99.00 Down 0.77(0.77%) 30 Jun 21:00 - Nasdaq Real Time Price
Add to Portfolio
Prev Close:N/A
Open:99.00
Bid:N/A
Ask:N/A
1y Target Est:93.57
Beta:0.97
Next Earnings Date:N/A
Day's Range:99.05 - 100.45
52wk Range:88.39 - 100.70
Volume:11,324,055
Avg Vol (3m):N/A
Market Cap:N/A
P/E (ttm):162.30
EPS (ttm):0.61
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in .

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Forest Laboratories, Inc., a specialty pharmaceutical company, develops, manufactures, and sells branded forms of ethical drug products in the United States and Europe. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback